The PI3K/AKT signaling pathway has been considered a significant cause of chemoresistance in cancer therapy, inhibition of apoptosis, stimulation of cell growth, and modulation of cellular metabolism[42] [Figure 1]. The gene discussed is AKT1; the disease is cancer.